TLR4 is believed to be part of the first immune barrier to bacterial infection in the gastrointestinal tract and can promote the release of cytokines by activating the NF-κB signaling pathway, thus activating innate immune response [29]. Here, TLR4 is linked to bacterial infectious disease.